Review Article
Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?
Table 1
Implication of TGF-β in peritoneal fibrosis.
| (i) Activates quiescent fibroblasts into myofibroblasts | (ii) Increases fibronectin production by fibroblast and MC | (iii) Induces the expression of connective tissue growth factor (CTGF) by MC | (iv) Stimulates the synthesis of PAI, the natural inhibitor of tPA, contributing to the generation of an antifibrinolytic environment | (v) Increases matrix synthesis and inhibits matrix degradation by decreasing the ratio MMPs/TIMPs | (vi) Induces MMT of MC |
|
|